EMAIL THIS PAGE TO A FRIEND

Seminars in nephrology

Animal models of FSGS: lessons for pathogenesis and treatment.


PMID 12704576

Abstract

Glomerulosclerosis in a heterogeneous pattern, ie, focal and segmental glomerulosclerosis (FSGS), is a common endpoint in a variety of settings, including idiopathic FSGS, and scarring secondary to other renal or systemic diseases. These different causes contribute to the diverse clinical outcomes of histological focal sclerosis, and the varying histologic manifestations of sclerosis. Numerous models have been established in the rat that aim to mirror the various elements of human glomerulosclerosis. With the availability of knockout gene technology, many, but not all of these models have been translated to mouse species. This review will focus on the remnant kidney model, the podocyte injury models of puromycin aminonucleoside or adriamycin injection, and examples of newly developed genetic models, such as knockout of CD2 associated protein (CD2AP).

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SBR00017
Puromycin aminonucleoside Ready Made Solution, 10 mg/mL in water
C12H18N6O3